Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interactions of Artemether-lumefantrine and Amodiaquine in Healthy Subjects
NCT04080895Phase 1Terminated
- Sponsor
- University of Oxford
- Start
- Nov 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of artemether + lumefantrine and amodiaquine in malaria (2 arms), sponsored by University of Oxford. Primary endpoints: Area under the concentration-time curve from time zero to infinity, Area under the concentration-time curve from time zero to the last measurable concentration and 1 more. Started Nov 2022; status: terminated.
02
Drugs
artemether + lumefantrineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04080895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080895.